MLTX MoonLake Immunotherapeutics | $19.02
| 9/14/2023 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 9/14/2023 |
TVTX Travere Therapeutics | $57.36
| 5/5/2023 | | Upgrade | | Sell ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Travere Therapeutics (NASDAQ:TVTX) on 5/5/2023 |
IMCR Immunocore | $35.00
| 3/24/2023 | | Initiated Coverage | $16.00 | Buy | 00.00% | View details for Bryan, Garnier & Co rating of Immunocore (NASDAQ:IMCR) on 3/24/2023 |
IMTX Immatics | $9.08
| 3/24/2023 | | Initiated Coverage | $16.00 | Buy | 00.00% | View details for Bryan, Garnier & Co rating of Immatics (NASDAQ:IMTX) on 3/24/2023 |
AUTL Autolus Therapeutics | $1.45
| 3/17/2023 | | Initiated Coverage | $5.00 | Buy | 00.00% | View details for Bryan, Garnier & Co rating of Autolus Therapeutics (NASDAQ:AUTL) on 3/17/2023 |
CLLS Cellectis | $2.84
| 3/17/2023 | | Initiated Coverage | $6.00 | Buy | 00.00% | View details for Bryan, Garnier & Co rating of Cellectis (NASDAQ:CLLS) on 3/17/2023 |
CRSP CRISPR Therapeutics | $46.54
| 3/17/2023 | | Initiated Coverage | $70.00 | Buy | 00.00% | View details for Bryan, Garnier & Co rating of CRISPR Therapeutics (NASDAQ:CRSP) on 3/17/2023 |
MLTX MoonLake Immunotherapeutics | $19.02
| 2/2/2023 | | Initiated Coverage | $22.00 | Buy | 00.00% | View details for Bryan, Garnier & Co rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 2/2/2023 |
HXGBY Hexagon | SEK 8.56
| 12/14/2022 | | Initiated Coverage | SEK 100 | Sell | 00.00% | View details for Bryan, Garnier & Co rating of Hexagon (OTCMKTS:HXGBY) on 12/14/2022 |
SAP SAP | €140.20
+9.3% | 12/14/2022 | | Set Price Target | €130.00 | | 00.00% | View details for Bryan, Garnier & Co rating of SAP (ETR:SAP) on 12/14/2022 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
CRRFY Carrefour | €3.56
| 11/16/2022 | | Downgrade | €22.00 ➝ €20.00 | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Carrefour (OTCMKTS:CRRFY) on 11/16/2022 |
TMSNY Temenos Group | CHF 75.08
| 10/17/2022 | | Downgrade | CHF 118 ➝ CHF 58 | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Temenos Group (OTCMKTS:TMSNY) on 10/17/2022 |
PHVS Pharvaris | $34.17
| 10/5/2022 | | Initiated Coverage | $16.00 | Buy | 00.00% | View details for Bryan, Garnier & Co rating of Pharvaris (NASDAQ:PHVS) on 10/5/2022 |
TVTX Travere Therapeutics | $57.36
| 9/21/2022 | | Initiated Coverage | $17.00 | Sell | 00.00% | View details for Bryan, Garnier & Co rating of Travere Therapeutics (NASDAQ:TVTX) on 9/21/2022 |
SGBAF SES | €8.00
| 9/20/2022 | | Initiated Coverage | €6.50 | Neutral | 00.00% | View details for Bryan, Garnier & Co rating of SES (OTCMKTS:SGBAF) on 9/20/2022 |
TAP Molson Coors Beverage | $40.98
+0.1% | 9/1/2022 | | Downgrade | $54.00 | Buy ➝ Sell | 00.00% | View details for Bryan, Garnier & Co rating of Molson Coors Beverage (NYSE:TAP) on 9/1/2022 |
ADRNY Ahold | €38.17
| 8/31/2022 | | Upgrade | €31.00 ➝ €34.00 | Neutral ➝ Buy | 00.00% | View details for Bryan, Garnier & Co rating of Ahold (OTCMKTS:ADRNY) on 8/31/2022 |
ADYEY Adyen | $9.01
| 8/19/2022 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Adyen (OTCMKTS:ADYEY) on 8/19/2022 |
CMPGY Compass Group | $30.39
| 6/9/2022 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Bryan, Garnier & Co rating of Compass Group (OTCMKTS:CMPGY) on 6/9/2022 |
ZLNDY Zalando | €15.53
| 6/1/2022 | | Downgrade | €87.00 ➝ €38.00 | Neutral ➝ Sell | 00.00% | View details for Bryan, Garnier & Co rating of Zalando (OTCMKTS:ZLNDY) on 6/1/2022 |
GMAB Genmab A/S | DKK 28.87
| 5/13/2022 | | Upgrade | | Sell ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Genmab A/S (NASDAQ:GMAB) on 5/13/2022 |
NVO Novo Nordisk A/S | $48.76
0.0% | 5/5/2022 | | Upgrade | | Sell ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Novo Nordisk A/S (NYSE:NVO) on 5/5/2022 |
IPSEY IPSEN | $44.81
| 4/27/2022 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of IPSEN (OTCMKTS:IPSEY) on 4/27/2022 |
BLDR Builders FirstSource | $72.89
+0.0% | 4/6/2022 | | Downgrade | $71.00 | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Builders FirstSource (NYSE:BLDR) on 4/6/2022 |
HNNMY Hennes & Mauritz | SEK 3.31
| 4/4/2022 | | Downgrade | SEK 225 ➝ SEK 190 | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Hennes & Mauritz (OTCMKTS:HNNMY) on 4/4/2022 |
DASTY Dassault Systemes | €22.55
| 3/25/2022 | | Downgrade | €49.00 | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Dassault Systemes (OTCMKTS:DASTY) on 3/25/2022 |
MTLS Materialise | $6.55
| 3/25/2022 | | Downgrade | $20.00 | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Materialise (NASDAQ:MTLS) on 3/25/2022 |
SDXAY Sodexo | €12.57
| 3/25/2022 | | Downgrade | €95.00 | Strong-Buy ➝ Buy | 00.00% | View details for Bryan, Garnier & Co rating of Sodexo (OTCMKTS:SDXAY) on 3/25/2022 |
HESAY Hermes International | $186.46
| 3/18/2022 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Bryan, Garnier & Co rating of Hermes International (OTCMKTS:HESAY) on 3/18/2022 |
TIIAY Telecom Italia | $8.33
| 3/14/2022 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Bryan, Garnier & Co rating of Telecom Italia (OTCMKTS:TIIAY) on 3/14/2022 |
ZLNDY Zalando | $15.53
| 3/4/2022 | | Downgrade | | Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Zalando (OTCMKTS:ZLNDY) on 3/4/2022 |
LKFT Lakefront Biotherapeutics American Depositary Shares | $27.84
| 1/28/2022 | | Upgrade | | Sell ➝ Buy | 00.00% | View details for Bryan, Garnier & Co rating of Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) on 1/28/2022 |
NVS Novartis | $154.84
-0.1% | 12/3/2021 | | Reiterated Rating | $115.00 ➝ $85.00 | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Novartis (NYSE:NVS) on 12/3/2021 |
AZN Astrazeneca | $168.68
-0.3% | 11/22/2021 | | Downgrade | | Buy | 00.00% | View details for Bryan, Garnier & Co rating of Astrazeneca (NYSE:AZN) on 11/22/2021 |
NVO Novo Nordisk A/S | DKK 48.76
0.0% | 11/3/2021 | | Downgrade | DKK 148.00 | Buy ➝ Sell | 00.00% | View details for Bryan, Garnier & Co rating of Novo Nordisk A/S (NYSE:NVO) on 11/3/2021 |
ESLOY EssilorLuxottica | $92.54
| 10/29/2021 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Bryan, Garnier & Co rating of EssilorLuxottica (OTCMKTS:ESLOY) on 10/29/2021 |
MTTRY Ceconomy | $0.79
| 10/12/2021 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Ceconomy (OTCMKTS:MTTRY) on 10/12/2021 |
BNTX BioNTech | $89.33
| 10/5/2021 | | Set Price Target | $359.00 | | 00.00% | View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 10/5/2021 |
CODYY Compagnie de Saint-Gobain | €8.42
| 10/1/2021 | | Upgrade | €80.00 | Neutral ➝ Buy | 00.00% | View details for Bryan, Garnier & Co rating of Compagnie de Saint-Gobain (OTCMKTS:CODYY) on 10/1/2021 |
BNTX BioNTech | $89.33
| 9/24/2021 | | Set Price Target | $451.00 | | 00.00% | View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 9/24/2021 |
A letter from Shannon Stansberry (Ad) Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief.
It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. Watch the full story and see the verified track record for yourself |
VALN Valneva | $4.78
| 9/13/2021 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Valneva (NASDAQ:VALN) on 9/13/2021 |
ERFSF Eurofins Scient | $73.75
| 8/25/2021 | | Downgrade | | Strong-Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Eurofins Scient (OTCMKTS:ERFSF) on 8/25/2021 |
BNTX BioNTech | $89.33
| 8/11/2021 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 8/11/2021 |
BOUYF Bouygues | $59.34
| 7/27/2021 | | Upgrade | $37.20 | Neutral ➝ Buy | 00.00% | View details for Bryan, Garnier & Co rating of Bouygues (OTCMKTS:BOUYF) on 7/27/2021 |
ERFSF Eurofins Scient | $73.75
| 7/9/2021 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Eurofins Scient (OTCMKTS:ERFSF) on 7/9/2021 |
LGRDY LeGrand | $30.33
| 6/29/2021 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of LeGrand (OTCMKTS:LGRDY) on 6/29/2021 |
CODYY Compagnie de Saint-Gobain | $8.42
| 6/9/2021 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Compagnie de Saint-Gobain (OTCMKTS:CODYY) on 6/9/2021 |
MOR MorphoSys | $18.96
| 6/3/2021 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of MorphoSys (NASDAQ:MOR) on 6/3/2021 |
BNTX BioNTech | $89.33
| 5/17/2021 | | Reiterated Rating | $135.00 ➝ $206.00 | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 5/17/2021 |
BAYRY Bayer Aktiengesellschaft | $13.13
| 5/13/2021 | | Upgrade | | Sell ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Bayer Aktiengesellschaft (OTCMKTS:BAYRY) on 5/13/2021 |
BNTX BioNTech | $89.33
| 5/11/2021 | | Downgrade | $135.00 ➝ $206.00 | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 5/11/2021 |
BUD Anheuser-Busch InBev SA/NV | $81.67
+0.0% | 5/6/2021 | | Upgrade | | Sell ➝ Buy | 00.00% | View details for Bryan, Garnier & Co rating of Anheuser-Busch InBev SA/NV (NYSE:BUD) on 5/6/2021 |
DBVT DBV Technologies | $13.63
| 5/3/2021 | | Upgrade | | Sell ➝ Buy | 00.00% | View details for Bryan, Garnier & Co rating of DBV Technologies (NASDAQ:DBVT) on 5/3/2021 |
MTLS Materialise | $6.55
| 3/10/2021 | | Upgrade | $43.00 | Neutral ➝ Buy | 00.00% | View details for Bryan, Garnier & Co rating of Materialise (NASDAQ:MTLS) on 3/10/2021 |
ECIFY Electricité de France | $2.55
| 2/24/2021 | | Downgrade | | Neutral ➝ Sell | 00.00% | View details for Bryan, Garnier & Co rating of Electricité de France (OTCMKTS:ECIFY) on 2/24/2021 |
BDRFY Beiersdorf Aktiengesellschaft | $17.70
| 2/17/2021 | | Downgrade | | Neutral ➝ Sell | 00.00% | View details for Bryan, Garnier & Co rating of Beiersdorf Aktiengesellschaft (OTCMKTS:BDRFY) on 2/17/2021 |
IPHYF Innate Pharma | $1.65
| 2/9/2021 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Bryan, Garnier & Co rating of Innate Pharma (OTCMKTS:IPHYF) on 2/9/2021 |
DASTY Dassault Systemes | $22.55
| 2/5/2021 | | Upgrade | | Sell ➝ Buy | 00.00% | View details for Bryan, Garnier & Co rating of Dassault Systemes (OTCMKTS:DASTY) on 2/5/2021 |
SDXAY Sodexo | $12.57
| 2/3/2021 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Bryan, Garnier & Co rating of Sodexo (OTCMKTS:SDXAY) on 2/3/2021 |
IFNNY Infineon Technologies | $72.06
| 1/14/2021 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Infineon Technologies (OTCMKTS:IFNNY) on 1/14/2021 |
VCISY Vinci | $33.44
| 1/14/2021 | | Upgrade | | Sell ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Vinci (OTCMKTS:VCISY) on 1/14/2021 |
STM STMicroelectronics | $51.39
-0.3% | 1/8/2021 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Bryan, Garnier & Co rating of STMicroelectronics (NYSE:STM) on 1/8/2021 |
CODYY Compagnie de Saint-Gobain | $8.42
| 1/7/2021 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Bryan, Garnier & Co rating of Compagnie de Saint-Gobain (OTCMKTS:CODYY) on 1/7/2021 |
LKFT Lakefront Biotherapeutics American Depositary Shares | $27.84
| 12/17/2020 | | Downgrade | | Buy ➝ Sell | 00.00% | View details for Bryan, Garnier & Co rating of Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) on 12/17/2020 |
SCRYY Scor | $3.88
| 12/17/2020 | | Downgrade | | Buy | 00.00% | View details for Bryan, Garnier & Co rating of Scor (OTCMKTS:SCRYY) on 12/17/2020 |
ITMPF Itm Power | $1.41
| 12/11/2020 | | Initiated Coverage | | Buy | 00.00% | View details for Bryan, Garnier & Co rating of Itm Power (OTCMKTS:ITMPF) on 12/11/2020 |
STM STMicroelectronics | $51.39
-0.3% | 12/10/2020 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of STMicroelectronics (NYSE:STM) on 12/10/2020 |
IPSEY IPSEN | $44.81
| 12/2/2020 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of IPSEN (OTCMKTS:IPSEY) on 12/2/2020 |
BAYRY Bayer Aktiengesellschaft | $13.13
| 10/1/2020 | | Downgrade | | Neutral ➝ Sell | 00.00% | View details for Bryan, Garnier & Co rating of Bayer Aktiengesellschaft (OTCMKTS:BAYRY) on 10/1/2020 |
GMAB Genmab A/S | $28.87
| 9/23/2020 | | Downgrade | | Neutral ➝ Sell | 00.00% | View details for Bryan, Garnier & Co rating of Genmab A/S (NASDAQ:GMAB) on 9/23/2020 |
IHG Intercontinental Hotels Group | $156.33
+0.1% | 9/21/2020 | | Downgrade | | Neutral ➝ Sell | 00.00% | View details for Bryan, Garnier & Co rating of Intercontinental Hotels Group (NYSE:IHG) on 9/21/2020 |
IPHA Innate Pharma | $1.78
| 9/9/2020 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Innate Pharma (NASDAQ:IPHA) on 9/9/2020 |
DBVT DBV Technologies | $13.63
| 8/4/2020 | | Downgrade | | Neutral ➝ Sell | 00.00% | View details for Bryan, Garnier & Co rating of DBV Technologies (NASDAQ:DBVT) on 8/4/2020 |
BUD Anheuser-Busch InBev SA/NV | $81.67
+0.0% | 7/15/2020 | | Downgrade | | Buy ➝ Sell | 00.00% | View details for Bryan, Garnier & Co rating of Anheuser-Busch InBev SA/NV (NYSE:BUD) on 7/15/2020 |
TAP Molson Coors Beverage | $40.98
+0.1% | 7/15/2020 | | Upgrade | $49.00 | Sell ➝ Buy | 00.00% | View details for Bryan, Garnier & Co rating of Molson Coors Beverage (NYSE:TAP) on 7/15/2020 |
DEO Diageo | $83.12
+0.1% | 7/8/2020 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Bryan, Garnier & Co rating of Diageo (NYSE:DEO) on 7/8/2020 |
BNTX BioNTech | $89.33
| 7/2/2020 | | Boost Price Target | $50.00 ➝ $62.00 | | 00.00% | View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 7/2/2020 |
STM STMicroelectronics | $51.39
-0.3% | 6/29/2020 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Bryan, Garnier & Co rating of STMicroelectronics (NYSE:STM) on 6/29/2020 |
GMAB Genmab A/S | $28.87
| 6/3/2020 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Genmab A/S (NASDAQ:GMAB) on 6/3/2020 |
AZN AstraZeneca | £126.70
| 6/2/2020 | | Boost Price Target | GBX 8,780 ➝ GBX 9,100 | Buy | 00.00% | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 6/2/2020 |
CGC Canopy Growth | $0.89
+0.2% | 6/1/2020 | | Downgrade | | Neutral ➝ Sell | 00.00% | View details for Bryan, Garnier & Co rating of Canopy Growth (NASDAQ:CGC) on 6/1/2020 |
AZN AstraZeneca | £126.70
| 5/11/2020 | | Boost Price Target | GBX 8,550 ➝ GBX 8,780 | Buy | 00.00% | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 5/11/2020 |
DBVT DBV Technologies | $13.63
| 3/18/2020 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of DBV Technologies (NASDAQ:DBVT) on 3/18/2020 |
SGE The Sage Group | GBX 843.38
| 3/2/2020 | | Lower Price Target | GBX 690 ➝ GBX 680 | Neutral | 00.00% | View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 3/2/2020 |
BUD Anheuser-Busch InBev SA/NV | $81.67
+0.0% | 2/28/2020 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Anheuser-Busch InBev SA/NV (NYSE:BUD) on 2/28/2020 |
ACB Aurora Cannabis | $2.67
| 2/27/2020 | | Downgrade | | Neutral ➝ Sell | 00.00% | View details for Bryan, Garnier & Co rating of Aurora Cannabis (NASDAQ:ACB) on 2/27/2020 |
GSK GSK | GBX 1,919.50
| 2/6/2020 | | Lower Price Target | GBX 1,800 ➝ GBX 1,773 | Neutral | 00.00% | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 2/6/2020 |
SAP SAP | €140.20
+9.3% | 1/28/2020 | | Set Price Target | €153.00 | Buy | 00.00% | View details for Bryan, Garnier & Co rating of SAP (ETR:SAP) on 1/28/2020 |
ASML ASML | $1,757.09
| 1/14/2020 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Bryan, Garnier & Co rating of ASML (NASDAQ:ASML) on 1/14/2020 |
BRBY Burberry Group | GBX 1,043
| 1/10/2020 | | Boost Price Target | GBX 1,780 ➝ GBX 1,860 | Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 1/10/2020 |
Porter flew 3,300 miles to investigate this system (Ad) Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film.
Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business. Watch the full investigation and decide for yourself |
AZN AstraZeneca | £126.70
| 12/19/2019 | | Reiterated Rating | | Buy | 00.00% | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 12/19/2019 |
GSK GSK | GBX 1,919.50
| 12/19/2019 | | Boost Price Target | GBX 1,660 ➝ GBX 1,747 | Neutral | 00.00% | View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 12/19/2019 |
AZN AstraZeneca | £126.70
| 11/25/2019 | | Upgrade | GBX 7,700 ➝ GBX 7,950 | Buy | 00.00% | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 11/25/2019 |
CABGY Carlsberg AS | $27.69
| 8/12/2019 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Bryan, Garnier & Co rating of Carlsberg AS (OTCMKTS:CABGY) on 8/12/2019 |
TAP Molson Coors Beverage | $40.98
+0.1% | 8/1/2019 | | Reiterated Rating | $51.00 | Neutral ➝ Sell | 00.00% | View details for Bryan, Garnier & Co rating of Molson Coors Beverage (NYSE:TAP) on 8/1/2019 |
CGC Canopy Growth | $0.89
+0.2% | 7/5/2019 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Canopy Growth (NASDAQ:CGC) on 7/5/2019 |
WEED Canopy Growth | C$1.27
| 7/4/2019 | | Downgrade | C$85.00 ➝ C$60.00 | Buy ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Canopy Growth (TSE:WEED) on 7/4/2019 |
AZN AstraZeneca | £126.70
| 7/3/2019 | | Reiterated Rating | | Neutral | 00.00% | View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 7/3/2019 |
BRBY Burberry Group | GBX 1,043
| 5/20/2019 | | Upgrade | | Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 5/20/2019 |
BURBY Burberry Group | $14.16
| 5/20/2019 | | Upgrade | | Sell ➝ Neutral | 00.00% | View details for Bryan, Garnier & Co rating of Burberry Group (OTCMKTS:BURBY) on 5/20/2019 |
